Omnicell, Inc. (NASDAQ:OMCL) Stock Position Lessened by Driehaus Capital Management LLC

Driehaus Capital Management LLC reduced its stake in shares of Omnicell, Inc. (NASDAQ:OMCL) by 1.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 212,960 shares of the company’s stock after selling 2,419 shares during the quarter. Driehaus Capital Management LLC’s holdings in Omnicell were worth $9,481,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of OMCL. Smartleaf Asset Management LLC raised its position in shares of Omnicell by 51.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 803 shares of the company’s stock worth $35,000 after buying an additional 273 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in Omnicell during the fourth quarter worth approximately $37,000. Van ECK Associates Corp lifted its position in Omnicell by 47.0% in the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company’s stock worth $44,000 after purchasing an additional 315 shares during the period. Headlands Technologies LLC bought a new position in Omnicell during the 4th quarter valued at $53,000. Finally, First Horizon Advisors Inc. increased its position in shares of Omnicell by 36.3% during the 4th quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company’s stock valued at $59,000 after purchasing an additional 355 shares during the period. Institutional investors and hedge funds own 97.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Wells Fargo & Company lowered their target price on Omnicell from $38.00 to $31.00 and set an “equal weight” rating on the stock in a report on Wednesday. Benchmark dropped their target price on shares of Omnicell from $62.00 to $40.00 and set a “buy” rating on the stock in a report on Wednesday. StockNews.com lowered shares of Omnicell from a “buy” rating to a “hold” rating in a research note on Saturday, May 3rd. Finally, JPMorgan Chase & Co. dropped their price target on Omnicell from $44.00 to $36.00 and set a “neutral” rating on the stock in a report on Thursday, March 20th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $45.83.

Omnicell Stock Performance

Omnicell stock opened at $25.88 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.37 and a quick ratio of 1.22. The company has a market cap of $1.21 billion, a P/E ratio of 95.86, a price-to-earnings-growth ratio of 7.53 and a beta of 0.78. Omnicell, Inc. has a fifty-two week low of $22.66 and a fifty-two week high of $55.75. The firm’s 50 day simple moving average is $32.28 and its 200-day simple moving average is $39.96.

Omnicell (NASDAQ:OMCL) last announced its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.10. Omnicell had a net margin of 1.13% and a return on equity of 3.82%. The company had revenue of $269.67 million for the quarter, compared to the consensus estimate of $260.18 million. During the same period in the previous year, the business earned $0.03 EPS. The company’s revenue was up 9.5% on a year-over-year basis. As a group, equities research analysts predict that Omnicell, Inc. will post 1.09 EPS for the current year.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.